$39 Million Repayment Order Prompts Restructuring at Amedisys

Baton Rouge-based Amedisys (Nasdaq: AMED), one of the nation’s largest home health care providers, has been slapped with a request by a Medicare contractor to repay nearly $39 million in overpayments, according to a public filing.

While Amedisys is appealing the allegations, it estimated the potential range of loss between $6.5 million and $38.8 million on Tuesday.

At the end of August, the company received a Request for Repayment from Palmetto, a Medicare administrative contractor (MAC), for an alleged overpayment of $34 million at its Infinity Home Care of Lakeland, LLC, location, which includes the Winterhaven, Tampa and Bradenton, Florida care centers—the Lakeland Care Centers.

Amedisys also received a request for payment for $4.8 million from overpayments at Infinity Home Care of Pinellas, LLC, which includes the Clearwater, Florida, care center, Pinellas Care Center.

Amedisys acquired both centers at the end of 2015.

The letters from Palmetto were based on statistical extrapolations performed by a Zone Program Integrity Contractor (ZPIC), a contracted Medicare auditor. The claims used in the extrapolation method range from January 2, 2014 to September 13, 2016 for Lakeland, and between January 2, 2015 and December 9, 2016 for Pinellas.

Amedisys disputes both the allegations, stating they “lack merit,” in a public filing. Amedisys filed appeals of individual claims used to calculate the extrapolated overpayment and will “aggressively challenge” the method that determined the overpayments.

At the same time, Amedisys also announced it will close four Florida home health care centers, consolidate another three home health centers with others in the same markets and implement a restructuring plan in its home health segment. These actions will incur approximately $2 million in costs during the third quarter of 2017 and $2 million to $3 million in the fourth quarter. The actions will also be completed in the fourth quarter of 2017.

Amedisys projects that the plans announced Tuesday will bring $7 million to $9 million in annual improvements in EBITDA.

By end of day trading Tuesday, Amedisys’ stock had dropped more than 3%, hovering $54 per share.

Written by Amy Baxter

Photo Credit:

Amy Baxter on EmailAmy Baxter on Twitter
Amy Baxter
Assistant Editor at Home Health Care News
When not writing about all things home health, Amy fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."



, ,

By continuing to use the site, you agree to the use of cookies. More Information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this. For more information, see our cookie policy